Treating hidradenitis suppurativa patients with adalimumab: a real-life experience of a tertiary care center in Lisboa, Portugal
Main Authors: | José Miguel Neves, Nélia Cunha, André Lencastre, Joana Cabete |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Dermatologia
2022-11-01
|
Series: | Anais Brasileiros de Dermatologia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962022000600816&lng=en&tlng=en |
Similar Items
-
Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
by: Ryan C. Saal, BS, et al.
Published: (2023-06-01) -
Optic neuropathy in a patient treated with adalimumab for hidradenitis suppurativa
by: Sarah Alnaif, BHSc, et al.
Published: (2023-07-01) -
ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa
by: Alexander Craig, et al.
Published: (2023-04-01) -
A complication in a patient with hidradenitis suppurativa taking adalimumab
by: Olivia D. Perez, BA, et al.
Published: (2022-09-01) -
Pathophysiology of hidradenitis suppurativa: a systematic review of the literature
by: Pedro Mendes-Bastos, et al.
Published: (2022-10-01)